Fractionations in radiotherapy of brain metastases

Tumori

Volumn 90, Issue 1, 2004, Pages 80-85

  Portaluri, Maurizio ^a   Bambace, Santa ^a   Giuliano, Giuseppe ^a   Di Paola, Lucia ^b   Gianicolo, Maria Elena ^b   Distante, Simona ^b   Casciaro, Sergio ^b  

^a A Perrino Hospital   (Italy)

^b ISBEM   (Italy)

Author keywords

Brain metastases; Dose fractionation; Neurological state; Radiotherapy

Indexed keywords

COBALT;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BRAIN METASTASIS; CANCER RADIOTHERAPY; COBALT THERAPY; CONTROLLED STUDY; EVALUATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MEDICAL RECORD; MENTAL HEALTH; MULTIVARIATE ANALYSIS; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 2142758140     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160409000117     Document Type: Article

References (21)

1. Sorensen JB, Hansen HH, Hansen M, Donbernowsky P: Brain metastases in adenocarcinoma of the lung: frequency, risk, groups and prognosis. J Clin Oncol, 6: 1474-1480, 1988.
2. Sparrow GE, Rubens RD: Brain metastases from breast cancer: clinical course, prognosis and influence on treatment. Clin Oncol, 7: 291-301, 1981.
3. Amer MH, Al-Sarraf M, Baker LH, Vaitkevicious VK: Malignant melanoma and CNS metastases. Incidence, diagnosis, treatment and survival. Cancer, 42: 660-667, 1978.
4. Nussbaum ES, Djalilian HR, Cho KH, Hall WA: Brain metastases. Histology, multiplicity, surgery and survival. Cancer, 78: 1781-1787, 1996.
5. Harada Y, Nonomura N, Kondo M, Nishimura K, Takahara S, Miki T, Hokuyama A: Clinical study of brain metastasis of renal cell carcinoma. Eur Urol, 36: 230-235, 1999.
6. Merchut MP: Brain metastases from undiagnosed systemic neoplasms. Arch Int Med, 149: 1076-1080, 1989.
7. Yardeni D, Reichenthal E, Zucker G, Rubeinstein A, Cohen M, Israeli V, Shali MN: Neurosurgical management of single brain metastases. Surg Neurol, 21: 377-384, 1984.
8. Debevec M: Management of patients with brain metastases of unknown origin. Neoplasma, 37: 600-606, 1990.
9. De Angelis LM: The management of a single CNS metastasis. In: Challenges in neurology, Hachinsky VC (Ed), pp 257-268, FA Davis, Philadelphia, 1992.
10. Gaspar LE, Scott C, Murray K, Curran W: Validation of RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys, 47: 1001-1006, 2000.
11. Vermeulen SS: Whole brain radiotherapy in the treatment of metastatic brain tumor. Semin Surg Oncol, 14: 64-69, 1998.
12. Murray KJ, Scott C, Greenberg HM, Emami B, Seider M, Vora NL, Olson C, Whitton A, Movsas B, Curran W: A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys, 39: 571-574, 1997.
13. Komarnicky LT, Phillips TL, Martz K, Asbell S, Isaacson S, Urtasun R: A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastase (RTOG-7916). Int J Radiat Oncol Biol Phys, 20: 53-58, 1991.
14. Phillips TL, Scott CB, Leibel SA, Rotman M, Weigensberg IJ: Results of randomised comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 8905. Int J Radiat Oncol Biol Phys, 33: 339-348, 1995.
15. Viala J, Vanel D, Meigan P, Lartigau E, Carde P, Renschler M: Phases IB and II multidose trail of gadolinium texaphyrin, a radiation sensitizer detectable at MR imaging: preliminary results in brain metastases. Radiology, 212: 755-759, 1999.
16. Carde P, Timmerman R, Mehta MP, Koprowski CD, Ford J, Tishler RB, Miles D, Miller RA, Renshler MF: Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases. J Clin Oncol, 19: 2074-2083, 2001.
17. Sanghavi SN, Miranpuri SS, Chappell R, Buatti JM, Sneed PK, Suh JH, Regine WF, Weltman E, King VJ, Goetsch SJ, Breneman JC, Sperduto PW, Scott C, Mabanta S, Mehta MP: Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys, 51: 426-434, 2001.
18. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC: Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys, 45: 427-434, 1999.
19. Sperduto PW, Scott C, Andrews D, Shell M, Werner-Wasik M, Demas W, Ryu JK, Fontanesi J: Preliminary report of RTOG 9508: A phase III randomised trial comparing whole brain irradiation plus stereotactic radiosurgery for patients with two or three unresected brain metastases. Int J Radiat Oncol Biol Phys, 48 (Suppl 3): 113, 2000.
20. American College of Radiology: ACR appropriateness criteria, pre-irradiation evaluation and management of brain metastases, American College of Radiology (Ed), pp 1105-1135; Reston (VA), USA, 2003.
21. Hoffman R, Sneed PK, McDermott MW, Chang S, Lamborn KR, Park E, Wara WM, Larson DA: Radiosurgery for brain metastases from primary lung carcinoma. Cancer J, 7: 121-131, 2001.